Skip to main content

Doctoral theses

Theses written based on research within the research group

  

Theses beyond the research group itself

 

The following theses were also based on original research in part carried out in collaboration with members of the research group:

Alan Harris, PhD thesis (Uppsala University, Uppsala, Sweden) Intranasal administration of peptides. The effects of formulation and delivery systems on: nasal deposition, biological response and bioavailability of desmopressin. Defended in 1988.

Britt Beding-Barnekow, PhD thesis (Lund University, Lund, Sweden) Antidromic relexes in the rabbit eye. Role of peptides in sensory nerve fibres. Defended in 1988.

Malcolm S. Reid, PhD thesis (Karolinska Institute, Stockholm, Sweden) Neuropharmacological circuitry of the basal ganglia studied by in vivo microdialysis. Defended in 1990.

Lena Danielsson, PhD thesis (Lund University, Lund, Sweden) Human monoclonal antibodies. In vitro immunization and cloning of DNA encoding variable regions. Defended in 1990.

Stefan Lethagen, PhD thesis (Lund University, Lund, Sweden) Pharmacokinetics, biological and clinical effect and mechanism of action of DDAVP in normal volunteers and patients with bleeding disorders. The effect of different Factor VIII concentrates in von-Willebrand's disease type III. Defended in 1992.

Karin Kristensson, PhD thesis (Lund University, Lund, Sweden) T cell mediated effects on in vitro B cell responses. Defended in 1993.

Jorma Hinkula, PhD thesis (Karolinska Institute, Stockholm, Sweden) Functionally important HIV-1 B-cell determinants mapped with monoclonal antibodies. Defended in 1993.

Li-te Chin, PhD thesis (Lund University, Lund, Sweden) Site-directed in vitro immunization. A model of sequential antigen-specific activation of human B cells. Defended in 1994.

Marta Dueñas, PhD thesis (Lund University, Lund, Sweden) Phage display and bacterial expression of antibody fragments. Defended in 1995.

Peter Ifversen, PhD thesis (Lund University, Lund, Sweden) Human antibody technology. An evaluation of the SCID-hu-PBL model. Defended in 1995.

Christina Eriksson, PhD thesis (Lund University, Lund, Sweden) The SCID mouse. A tool for generation of human monoclonal antibodies? Defended in 1995.

Markus Eickmann, PhD thesis (Philipps-Universität Marburg, Marburg, Germany) Oligometrisierung und Komplexierung des HCMV-gB: Auswirkung der gezielten Mutagenese von Cysteinresten im carboxyterminalen Spaltfragment. Defended in 1996.

Christina Furebring, PhD thesis (Lund University, Lund, Sweden) Expression of Ig genes. Regulation of transcription and production of human antibodies. Defended in 1996.

Ann-Christin Malmborg, PhD thesis (Lund University, Lund, Sweden) Molecular recognition in antibody engineering. Studies on recombinant and phage displayed antibodies. Defended in 1996.

Marie Wallén-Öhman, PhD thesis (Lund University, Lund, Sweden) MHC class I-induced apoptosis in hematopoietic cells. Defended in 1996.

Christer Wingren, PhD thesis (Lund University, Lund, Sweden) Surface properties of antibodies and their complexes with antigens studied by LLPC. Defended in 1997.

Sylvia Bold, PhD thesis (Philipps-Universität Marburg, Marburg, Germany) Lokalisation fusionsrelevanter Domänen des Glykoproteins B des humanen Cytomegalievirus. Defended in 1997.

Katarina Dahlenborg, PhD thesis (Lund University, Lund, Sweden) Cellular and Molecular aspects of the germinal center reaction. Defended in 1998.

Eva Andersson, PhD thesis (Lund University, Lund, Sweden) Studies of T- and B-cells for the generation of human antigen specific antibodies. Defended in 1998.

Andrea Speckner, PhD thesis (der Friedrich-Alexander Universität Erlangen-Nürnberg, Nürnberg, Germany) Strukturelle und immunologische Charakterisierung von Antigen-Antikörper-Komplexen am Beispiel von Glykoprotein B des menschlichen Cytomegalovirus. Defended in 1999.

Michel Silvestri, PhD thesis (Karolinska Institute, Stockholm, Sweden) Glycoprotein B of human cytomegalovirus - target for neutralising antibodies - ligand for cellular receptors - inducer of autoimmunity? Defended in 2000.

Nina Nilsson, PhD thesis (Lund University, Lund, Sweden) In vivo and in vitro evolution of molecular mechanisms. Importance in B cell development and phage display. Defended in 2000

Claudia Devito, PhD thesis (Karolinska Institute, Stockholm, Sweden) Functional properties of antibodies in resistance against HIV-1 infection. Defended in 2002.

Dorothee Gickelhorn, PhD thesis (Philipps-Universität Marburg, Marburg, Germany) Untersuchungen zur pH-unabhängigen Membranfusion des Humanen Cytomegalievirus. Defended in 2002.

Peter Ellmark, PhD thesis (Lund University, Lund, Sweden) The CD40 receptor - target, tool and technology. Defended in 2002.

Magnus Strandh, PhD thesis (Lund University, Lund, Sweden) Insights into weak affinity antibody-antigen interactions. Studies using affinity chromatography and optical biosensors. Defended in 2000.

Susanne Knör, PhD thesis (der Friedrich-Alexander Universität Erlangen-Nürnberg, Nürnberg, Germany) Strukturelle und immunologische Charakterisierung der Antigenen Domäne 1 des Glykoproteines B des humanen Cytomegalovirus. Defended in 2003.

Kristina Lundberg, PhD thesis (Lund University, Lund, Sweden) Subsets of human dendritic cells and their role in allergy. Defended in 2009.

Erika Gustafsson, PhD thesis (Lund University, Lund, Sweden) Molecular evolution of a C5aR antagonist against inflammatory disease. Defended in 2009

Reine Johansson, PhD thesis (Linnæus University) The protein-carbohydrate interaction – analysis of transient biomolecular complexes. Defended in 2009.

Fredrika Gullfot, PhD thesis (Royal School of Technology (KTH), Stockholm, Sweden) On the engineering of proteins: methods and applications for carbohydrate-active enzymes. Defended in 2010.

Per Augustsson, PhD thesis (Lund University, Lund, Sweden) On microchannel acoustophoresis - Experimental considerations and life science applications. Defended in 2011.

Frida Pauly, PhD thesis (Lund University, Lund, Sweden) Biomarker discovery in cancer using affinity proteomics - Studies of B-cell lymphomas and breast cancer. Defended in 2014.

Frida Rydnert, PhD thesis (Lund University, Lund, Sweden) Circulating human basophils and dendritic cell subsets. Aspects of antigen recognition and presentation in type I allergic immune responses. Defended in 2015.

Anna Säll, PhD thesis (Lund University, Lund, Sweden) Recombinant antibodies – Tools for building proteomic platforms. Defended in 2015.

Jasmine King, PhD thesis (Stanford University, Stanford, CA, USA) IgE and B cell repertoires in human allergy and immunotherapy. Defended in 2016.

Niklas Thalén, PhD thesis (Royal Institute of Technology, Stockholm, Sweden) Mammalian protein expression and characterization tools for next generation biologics. Defended in 2021. 

Mats Ohlin.

Professor Mats Ohlin

Head of the Department

mats.ohlin@immun.lth.se
+46 46 222 43 22
skype: matsohlin

Department of Immunotechnology
Lund University
Medicon Village
Building 406
223 81 LUND

Page Manager: jana.hagman@immun.lth.se | 2021-02-24